Predictors of Liver Transplant Eligibility for Patients with Hepatocellular Carcinoma in a Safety Net Hospital
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Liver transplantation for patients with hepatocellular carcinoma (HCC) affords excellent long-term survival but is limited to patients with early stage tumors. Predictors for orthotopic liver transplantation eligibility are not well defined for patients in a safety-net hospital system.
To clarify the clinical presentation of HCC and define predictors for early stage disease in a racially diverse safety-net hospital system.
We retrospectively reviewed records of patients with HCC presenting to a large urban county hospital between January 1998 and October 2007. Logistic regression analysis was used to find predictors of OLT eligibility.
Of the 266 patients with HCC, 62% had multiple tumors, 47% had portal vein thrombosis and only 22% were potential liver transplant candidates based on Milan criteria. Male gender (OR 0.33; 95% CI 0.17–0.65) and AFP levels > 20 ng/mL (OR 0.22; 95% CI 0.11–0.45) were negative predictors of liver transplant eligibility. Age, race, and underlying viral liver disease were not significant predictors of early tumor stage.
A minority of HCC patients in a safety-net hospital are eligible for liver transplant at the time of diagnosis. Men have more advanced tumors at presentation, which may be related to more aggressive tumor biology or differential rates of HCC surveillance.
- Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27:1485–1491. CrossRef
- El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–2576. CrossRef
- Singal AG, Volk ML, Waljee A, et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther. 2009;30:37–47. CrossRef
- Llovet JM, Bruix J. Early diagnosis and treatment of hepatocellular carcinoma. Baillieres Best Pract Res Clin Gastroenterol. 2000;14:991–1008. CrossRef
- Ioannou GN, Perkins JD, Carithers RL Jr. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology. 2008;134:1342–1351. CrossRef
- Llovet JM, Bustamante J, Castells A, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999;29:62–67. CrossRef
- Regenstein M, Huang J. Stresses to the safety net: the public hospital perspective. In: Kaiser Commission on Medicaid and the Uninsured. Washington DC: Kaiser Family Foundation; 2005.
- Younossi ZM, Stepanova M. Hepatitis C virus infection, age, and Hispanic ethnicity increase mortality from liver cancer in the United States. Clin Gastroenterol Hepatol. 2010;8:718–723. CrossRef
- Artinyan A, Mailey B, Sachez-Leuge N, et al. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Cancer. 2010;116:1367–1377. CrossRef
- Wong RJ, Corley DA. Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States. Dig Dis Sci. 2009;54:2031–2039. CrossRef
- Hendifar AE, Yang D, Iqbal S, Lenz H, El-Khoueiry A. Gender disparities in hepatocellular cancer survival. J Clin Oncol. 2009;27:e15517.
- Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236. CrossRef
- Onaca N, Davis GL, Jennings LW, et al. Improved results of transplantation for hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl. 2009;15:574–580. CrossRef
- Kemmer N, Neff G, Secic M, et al. Ethnic differences in hepatocellular carcinoma: implications for liver transplantation. Dig Dis Sci. 2008;53:551–555. CrossRef
- Wong LL, Tasi N, Limm W, et al. Liver transplant for hepatocellular cancer: a treatment for the select few. Clin Transplant. 2004;18:205–210. CrossRef
- Haque M, Zariat A. Disparities in liver transplantation for localized hepatocellular carcinoma: race or socioeconomic class? Am J Gastroenterol. 2008;103:1839–1840. author reply 1840. CrossRef
- Axelrod DA, Pomfret EA. Race and sex disparities in liver transplantation: progress toward achieving equal access? JAMA. 2008;300:2425–2426. CrossRef
- Dohmen K, Sigematsu H, Irie K, et al. Longer survival in female than male with hepatocellular carcinoma. J Gastroenterol Hepatol. 2003;18:267–272. CrossRef
- Moylan CA, Brady CW, Johnson JL, et al. Disparities in liver transplantation before and after introduction of the MELD score. JAMA. 2008;300:2371–2378. CrossRef
- Englesbe MJ, Schaubel DE, Cai S, et al. Portal vein thrombosis and liver transplant survival benefit. Liver Transpl. 2010;16:999–1005. CrossRef
- Han K, Tzimas GN, Barkun JS, et al. Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation. Can J Gastroenterol. 2007;21:39–45.
- Peng SY, Chen WJ, Lai PL, et al. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Int J Cancer. 2004;112:44–50. CrossRef
- Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387–1395. CrossRef
- Predictors of Liver Transplant Eligibility for Patients with Hepatocellular Carcinoma in a Safety Net Hospital
Digestive Diseases and Sciences
Volume 57, Issue 2 , pp 580-586
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Hepatocellular carcinoma
- Tumor stage
- Liver transplantation
- Safety net hospital
- Industry Sectors
- Author Affiliations
- 1. Division of Digestive and Liver Diseases, Department of Internal Medicine, UT Southwestern Medical Center, 1801 Inwood Rd Suite 4.420B, Dallas, TX, 75390, USA
- 2. Parkland Memorial Hospital, Parkland Health and Hospital System, Dallas, TX, USA
- 3. Department of Clinical Sciences, University of Texas Southwestern, Dallas, TX, USA
- 4. Harold C. Simmons Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA